Membrane Protein Screening via Cell Doublet Adhesion

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for studying protein-protein interactions on cell membranes face challenges such as transient interactions being missed, high false positive rates, limited throughput, and difficulty in distinguishing direct versus indirect interactions, particularly for membrane proteins which are hard to extract and have short interaction times with weak forces.

Innovation Solution

A membrane protein interaction detecting platform based on cell doublets formation derived from specific adhesion effects in living cells, where cells expressing different membrane proteins are co-cultured, and specific doublets are screened to identify interacting proteins through sequencing and other methods.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If co-immunoprecipitation is used to study protein-protein interactions, then specific interactions can be detected, but transient interactions are missed and false positive rates are high

Engineering Contradiction:
Improvedetection accuracyVSAvoidinteraction duration
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent replaces traditional mechanical/biochemical methods (co-immunoprecipitation, yeast two-hybrid) with a microfluidic-based single-cell sequencing platform. This substitution enables direct observation of protein interactions in living cells without extraction, capturing transient interactions that traditional methods miss while reducing false positives through spatial-resolved single-cell analysis.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent creates a spatial copy of the cellular environment using microfluidic droplets that encapsulate single cells. This copying approach preserves the native interaction context while enabling high-throughput parallel analysis, allowing transient interactions to be captured and analyzed without the artifacts introduced by traditional biochemical extraction methods.

Inventive Principle:
Principle #26Copying

2Ease of manufacture

If traditional protein extraction methods are used, then interactions can be studied, but membrane proteins are hard to extract and have short interaction times with weak forces

Engineering Contradiction:
Improveextraction difficultyVSAvoidinteraction time
Core Design Contradiction:
Ease of manufactureVSDuration of action of moving object

Solution Approach 1:

The patent replaces mechanical extraction methods with a microfluidic-based single-cell sequencing platform that analyzes interactions directly in living cells. This eliminates the extraction step entirely, preserving weak and transient membrane protein interactions that would be lost during traditional extraction and purification processes.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent allows cells to maintain their native state and self-organize protein interactions within microfluidic droplets. The cellular environment itself serves the function of preserving interactions, eliminating the need for external extraction and manipulation that would disrupt weak membrane protein interactions.

Inventive Principle:
Principle #25Self-service

3Productivity

If high-throughput screening is implemented, then productivity increases, but measurement precision may be compromised

Engineering Contradiction:
Improvescreening throughputVSAvoidinteraction detection accuracy
Core Design Contradiction:
ProductivityVSMeasurement precision

Solution Approach 1:

The patent segments the screening process into single-cell units encapsulated in microfluidic droplets. Each droplet acts as an independent reaction chamber, enabling parallel high-throughput analysis while maintaining the precision of single-cell measurement. This segmentation allows thousands of interactions to be screened simultaneously without compromising detection accuracy.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent creates multiple identical copies of the single-cell analysis environment through microfluidic droplet generation. Each droplet is a precise copy containing a single cell and necessary reagents, enabling high-throughput parallel screening while maintaining the measurement precision of individual cell analysis through standardized droplet conditions.

Inventive Principle:
Principle #26Copying

4Difficulty of detecting and measuring

If complex multi-step protocols are used, then detection capability improves, but device complexity and ease of operation worsen

Engineering Contradiction:
Improvedetection capabilityVSAvoidprotocol complexity
Core Design Contradiction:
Difficulty of detecting and measuringVSDevice complexity

Solution Approach 1:

The patent merges multiple complex steps (protein extraction, interaction detection, sequencing preparation) into a single microfluidic droplet encapsulation step. This consolidation simplifies the overall protocol while maintaining detection capability, as the droplet environment preserves all necessary cellular components and conditions for interaction analysis throughout the workflow.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent creates a universal microfluidic droplet platform that performs multiple functions: cell encapsulation, interaction preservation, reagent delivery, and sequencing preparation. This multi-functional design eliminates the need for separate specialized equipment and protocols for each step, reducing overall device and protocol complexity while maintaining comprehensive detection capability.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This platform allows for efficient, high-throughput identification and screening of membrane protein interactions, enabling the detection of specific protein pairs and assessment of antibody titers with high specificity and simplicity.

Implementation Method 1

a membrane protein interaction detecting platform based on cell doublets formation derived from specific adhesion effects in living cells

Methodology Applied
Scientific EffectCell-cell adhesion: Adhesive

Data Source

PatentUS20240151731A1Membrane protein interaction screening platform based on cell-cell adhesion effects
Publication Date: 2024.05.09 SUZHOU INST OF SYST MEDICINE
  • US20240151731A1 patent drawing
  • US20240151731A1 patent drawing
  • US20240151731A1 patent drawing

AI summary

The present application relates to the field of cell immunity, and discloses an interacting protein screening platform for preparing a cell membrane. A cell membrane protein and a membrane protein encoding gene to be tested are respectively expressed in different cells; after staining, cells expressing different membrane proteins and cells expressing target proteins are co-incubated; and then interacting membrane proteins are obtained by screening, and specific sequences thereof are determined by sequencing. The screening platform provided in the present application can screen a variety of cell membrane proteins and membrane protein-based engineering cells, and has strong specificity, thereby greatly improving the efficiency of screening interacting proteins and reducing the difficulty, providing a simple and convenient tool for studying the mechanism of action of cell membrane proteins, and improving the screening throughput.